The Ethics Working Group on ZIKV Research and Pregnancy has authored a new publication in Vaccine , summarizing their recommendations for the Zika virus vaccine research agenda. The interdisciplinary working group  is led by investigators at the Johns Hopkins Berman Institute of Bioethics, The UNC Center for Bioethics, and the Kennedy Institute of Ethics at Georgetown University, as part of a multi-year project on on Pregnancy Research Ethics for Vaccines, Epidemics, and New Technologies (PREVENT), funded by the Wellcome Trust [203160/Z/16/Z].
This publication follows the release of Pregnant Women & the Zika Virus Vaccine Research Agenda: Ethics Guidance on Priorities, Inclusion, and Evidence Generation. The interactive guidance document  is organized around three overarching imperatives to ensure the ethical inclusion of the interests of pregnant women in the ZIKV vaccine research agenda and across the product life cycle:
- to pursue and prioritize development of ZIKV vaccines that will be acceptable for use by pregnant women;
- to collect data to inform judgments about safety and efficacy of administration in pregnancy; and
- to ensure pregnant women have fair access to participate in ZIKV vaccine trials that offer a reasonably favorable balance of potential benefits to research-related risks.
The Ethics Working Group on ZIKV Research and Pregnancy is part of a larger initiative which seeks ethical solutions to ensure that the health needs of pregnant women and their offspring are appropriately included in research efforts addressing emerging public health crises. More information on Pregnancy Research Ethics for Vaccines, Epidemics, and New Technologies (PREVENT) can be found at zikapregnancyethics.org